Walder Wyss advised Engimmune Therapeutics on the deal. Vischer advised the investors Pureos Bio-ventures and Novo Holdings. Engimmune Therapeutics completed a CHF 15.5m seed financing round co-led...
You must be a Standard 1 Year member to access this content.
Flick Gocke Schaumburg and Vogel Heerma Waitz advised HomeToGo on the deal. Wendelstein Vischer, KNPZ Rechtsanwälte and RGT Consultants advised e-domizil. HomeToGo announced the acquisition of e-domizil...
You must be a Standard 1 Year member to access this content.
Walder Wyss advised Versant Ventures on the deal. VISCHER advised Cimeo Therapeutics. Versant Ventures announced the debut of Cimeio Therapeutics, a biotechnology company developing a novel...
You must be a Standard 1 Year member to access this content.
Vischer advised Andean Telecom Partners on the deal. Andean Telecom Partners (“ATP”), a leading owner and operator of telecommunications infrastructure in the Andean Region, acquired BTS...
You must be a Standard 1 Year member to access this content.
Vischer advised the management of the Sowind group. Homburger advised Kering on the transaction. Kering entered into an agreement for the sale of its entire stake...
You must be a Standard 1 Year member to access this content.
Niederer Kraft Frey has advised Credit Suisse on the deal. Lenz & Staehelin advised Gilde Buy Out Partners in this transaction. VISCHER advised the co-founders and...
You must be a Standard 1 Year member to access this content.
Heuking and Vischer advised FairCap on the deal. FairCap GmbH announced the acquisition of NYCO Flexible Packaging GmbH (NYCO) from Clondalkin Group, a subsidiary of Dutch...
You must be a Standard 1 Year member to access this content.
VISCHER advised Nemis Technologies on the deal. NEMIS Technologies AG closed a CHF 7.75m Series A financing round with the participation of both institutional and private...
You must be a Standard 1 Year member to access this content.
Walder Wyss acted as Swiss legal counsel for Alloy Therapeutics Inc on the deal. Vischer advised deepCDR Biologics AG. Alloy Therapeutics, a biotechnology ecosystem company, acquired...
You must be a Standard 1 Year member to access this content.
VISCHER advised Anaveon on the deal. Anaveon AG, a Swiss clinical-stage immuno-oncology company, has agreed to a CHF 110m Series B financing led by incoming investor...
You must be a Standard 1 Year member to access this content.
VISCHER advised Optravis on the deal. msg systems ag, an international IT consulting and system integration company based in Munich, has acquired Optravis LLC, based in...
You must be a Standard 1 Year member to access this content.
Kellerhals Carrard advised Vifor Pharma on the transaction. Vischer advised Inositec on the deal. Vifor Pharma acquired the Swiss firm Inositec AG, a clinical stage biopharmaceutical company...
You must be a Standard 1 Year member to access this content.
